AMRN Amarin Corporation plc
Healthcare$14.09+0.00%OpenMarket Cap: $291.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.67
P/S
1.39
EV/EBITDA
-76.65
DCF Value
$-20.03
FCF Yield
8.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
52.5%
Operating Margin
-17.4%
Net Margin
-15.6%
ROE
-7.3%
ROA
-5.2%
ROIC
-7.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $43.3M | 41.0% | $-8.0M | $-10.5M | $— | — |
| Q4 null | $49.1M | 45.6% | $-2.3M | $-1.2M | $— | — |
| FY null | $213.6M | 56.6% | $-13.9M | $-38.8M | $— | — |
| Q3 null | $49.7M | 44.7% | $-11.1M | $-7.7M | $— | — |
| Q2 null | $72.7M | 69.2% | $-16.0M | $-14.1M | $— | — |
| Q1 null | $42.0M | 59.8% | $-16.8M | $-15.7M | $— | — |
| Q4 null | $62.3M | -15.4% | $-52.5M | $-48.6M | $— | — |
| FY null | $228.6M | 35.6% | $-91.8M | $-82.2M | $— | — |
| Q3 null | $42.3M | 38.5% | $-25.2M | $-25.1M | $— | — |
| Q2 null | $67.6M | 62.2% | $-524.6K | $1.5M | $— | — |
| Q1 null | $56.5M | 56.4% | $-13.6M | $-10.0M | $— | — |
| Q4 2023 | $75.4M | 59.4% | $-4.6M | $-5.8M | $-0.29 | — |